Phase 2
Completed N=10
Inflammation, Polyphenols, and Genetics
Overweight · Obese
Source: ClinicalTrials.gov NCT01568827 ↗
Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Mar 2016
Primary outcomePrimary: Serum IL-6 — 42.4; 34.3 (pg*hr)/mL
Summary
Pilot study to determine whether daily consumption of blackraspberry powder (high in polyphenols) can reduce markers of inflammation and to determine whether genetics influence baseline levels of inflammatory markers as well as individual's response to polyphenols. A total of 10 males participated in this cross-over study.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Serum IL-6 |
42.4; 34.3 | — |
Eligibility Criteria
Inclusion Criteria
- adult males over 55 years of age
- overweight or obese
Exclusion Criteria
- history of adverse reaction to berries or berry products
- history of adverse reaction to high-fat, high-calorie challenge meal
- significant liver or renal insufficiency
- significant cognitive impairment
Data sourced from ClinicalTrials.gov (NCT01568827). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.